Published in Women's Health Weekly, December 5th, 2002
Navelbine is not currently indicated for use in women with metastatic breast cancer.
The multicenter open-label trial enrolled 40 women with metastatic disease (spread to sites in the body beyond the breast) whose tumors over-expressed the HER2Neu oncogene, a growth-promoting protein that has been closely...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly